Tag: uterus

AstraZeneca’s Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial

by Index Investing News

May 26, 2023

Fotonen/iStock Editorial via Getty Images AstraZeneca (NASDAQ:AZN) said Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival (PFS) ...

GSK Jemperli gets FDA full approval to treat certain uterus cancer patients

by Index Investing News

February 10, 2023

Wirestock The U.S. Food and Drug Administration (FDA) granted full approval to GSK's (NYSE:GSK) Jemperli converting it from accelerated approval ...

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

No Result

View All Result

Tag: uterus

AstraZeneca’s Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial

GSK Jemperli gets FDA full approval to treat certain uterus cancer patients

Molson Coors: Close to-Time period Weak Efficiency Outlook Elevate Considerations

BREAKING: BitMEX Fined $100 Million For US Cash-Laundering Violations

Music Doc ‘Luther: By no means Too A lot’ Trailer Concerning the Vocal Virtuoso

FDA bans pink dye No. 3 from meals due to potential most cancers danger

RECOMMENDED

Molson Coors: Close to-Time period Weak Efficiency Outlook Elevate Considerations

BREAKING: BitMEX Fined $100 Million For US Cash-Laundering Violations

Music Doc ‘Luther: By no means Too A lot’ Trailer Concerning the Vocal Virtuoso

FDA bans pink dye No. 3 from meals due to potential most cancers danger

DoubleLine’s Gundlach says the Fed seems like Mr. Magoo, focuses an excessive amount of on ‘short-termism’

CATEGORIES

Welcome Back!

Retrieve your password